CNS CANCER

Clinical trials for CNS CANCER explained in plain language.

Never miss a new study

Get alerted when new CNS CANCER trials appear

Sign up with your email to follow new studies for CNS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1

New Gadolinium-Free MRI dye could make brain scans safer

Diagnosis Completed

This study tested a new MRI contrast agent called RVP-001, which does not contain gadolinium, in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions compared to standard gado…

Matched conditions: CNS CANCER

Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis

Last updated May 17, 2026 02:03 UTC

CNS CANCER

Get alerted when new CNS CANCER trials appear

New Gadolinium-Free MRI dye could make brain scans safer